ITC Must Consider Amgen, Roche Dispute Over Mircera
The U.S. Court of Appeals for the Federal Circuit issued an order Wednesday sending the case back to the ITC, finding that the commission does have the authority to determine whether Roche's activities in developing and importing the...
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login